Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131
Debbie Guadagno - Cancer Research Institute
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => 1B6E4036220E8A9EFB513DBCBB3C6027.app30119b [routing_id] => 00000000.app30119b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30119b?NONCE_TOKEN=C002ABF7FBEA83D9C390FF41DBFDFF9E [token] => 7D5Lz0YmnF1r6ADoR9m3qbusgKGiRXaIxu75RiIjZDDqD2mZXZLipRi458gs1Co_brOElQcPZD9Ls0iu8F6NYQUINTJsDndTLSqZ2zc ) ) test
Immunotherapy Patient Stories

Debbie Guadagno

Area of Research: Kidney Cancer

Kidney Cancer

Debbie’s Story

Just before Christmas in 2014, Debbie Guadagno was looking forward to spoiling her grandkids with presents and spending time at family events. She had no idea that a tumor the size of a football was growing on her kidney until a routine blood test showed elevated calcium levels and she was sent for further testing. Scans showed that the cancer had spread to her liver, lung, and spine. Told she had 18 months to live at best, she found her way “through a stroke of luck” into a clinical trial testing a combination of two immunotherapies—ipilimumab (Yervoy®) and nivolumab (Opdivo®)—as a first-line treatment following surgical removal of the tumor. With the help of her husband, Gary, and sister, Cindy, Debbie made it to all her appointments, receiving treatment for two years before going off the trial. In April of this year—more than four years after her diagnosis—she was declared cancer-free by her medical team.

This site is registered on wpml.org as a development site.